Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Vivo Capital »

Arrivent Biopharma shares owned by Vivo Capital

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Vivo Capital

Quarter filed	Position value	Share count	Share price at filing
2026-03-31	$20M	886k	23.07

More positions owned by Vivo Capital

Erasca Common (ERAS)

Praxis Precision Medicines Common (PRAX)

Terns Pharmaceuticals Common (TERN)

Trevi Therapeutics Common (TRVI)

DBV Technologies SA Sponsored Ads (DBVT)

Compass Therapeutics Common (CMPX)

Tango Therapeutics Common (TNGX)

SAB Biotherapeutics Common (SABS)

Corvus Pharmaceuticals Holdings Common (CRVS)

Bright Minds Biosciences Common (DRUG)

Sinovac Biotech SHS

Dianthus Therapeutics Common (DNTH)

Dyne Therapeutics Common (DYN)

Abivax SA - Sponsored Ads (ABVX)

Minerva Neurosciences Common (NERV)

View all positions for Vivo Capital

Top funds holding Arrivent Biopharma

Suvretta Capital Management

Infinitum Asset Management

Hillhouse Capital Advisors

OrbiMed Advisors

Octagon Capital Advisors

Sofinnova Ventures

Vanguard Capital Management

General Catalyst Group Management

State Street Corporation

Goldman Sachs Group

View all funds holding Arrivent Biopharma

© 2026 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z